Industry

Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler

The Hindu - Industry·15 Sep 2026
Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler

The product will be manufactured at subsidiary Aurolife Pharma’s Raleigh facility in North Carolina and expected to be launched in upcoming quarters.

More news in Industry